Leal Health
Formerly TrialJectory
AI-based Decision Support Platform for Cancer Treatment
Startup B Health Tech & Life Sciences Est. 2017
Total Raised
$54.2M
B
Last Round
$26M
6 rounds
Investors
8
8 public
Team
6
11-50 employees
Confidence
100/100
News
17
articles
About
Leal Health is a growing patient-first, AI-powered decision support platform dedicated to expediting access to all available advanced cancer treatments. Working directly with patients, healthcare providers, and pharmaceutical companies, Leal Health provides patients with instant access to precise, advanced cancer treatment while also enabling the pharmaceutical and biotech industries to develop patient-centric clinical trials and provide real-time analytics and understanding of patient barriers and motivations. Leal Health was chosen as one of TIME magazine’s “100 Best Inventions of 2020,” was named an honoree in Fast Company’s 2021 “World-Changing Ideas Awards” in the AI and data category, and recognized as the “Leader in Patient Recruitment and Enrollment” by CBInsights.
Classification
Sector
Health Tech & Life SciencesDigital HealthcarePatient EngagementRetail PlatformsServices
Core Technology
Platforms & InterfacesSoftwareArtificial Intelligence
Target Customer
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcareProvidersPatients
Business Model
B2BB2B2C
Tags
saasdecision-supportmachine-learningpatientspharma-companiesoncologymarketplaceactionable-insightsartificial-intelligencedoctorscancernatural-language-processingdeep-learningdigital-healthcareweb-platformclinical-datapatient-engagementclinical-trials
Funding & Events
Sep 2021
Non-equity Undisclosed
BIRD Foundation
Feb 2022
A Round $20M
Insight Partners (Lead), Contour Venture Partners, TIA Ventures, Rho Capital Partners, JAL Ventures
Feb 2021
A Round $5M
Contour Venture Partners (Lead), Connecticut Innovations, TIA Ventures, Rho Capital Partners
Dec 2019
Seed $2.7M
Contour Venture Partners (Lead)
Apr 2024
B Round $26M
Ineffable Ventures (Lead)
Undisclosed Round $500K
Undisclosed Investor(s)
News (17)
Dec 5, 2023 · www.fiercebiotech.com
growth-positive
Leal Health boosts patient platform to include 'generative' AI
Customers
Jun 21, 2023 · www.fiercebiotech.com
growth-positive
Leal Health adds a 'first' with FDA-approved cancer treatment decision support service
CustomersExpand
Dec 7, 2022 · www.prnewswire.com
growth-positive
New Trialjectory Data Shows Triple-Negative Breast Cancer Patients More Likely to Seek Clinical Trial Options Prior to Treatment for Advanced Disease
Customers
Dec 5, 2022 · www.prnewswire.com
growth-positive
Trialjectory Grows Pharmaceutical and Biotech Clinical Trial Partnerships by 800 Percent
PartnersCustomersInvestment
Jun 22, 2022 · www.prnewswire.com
growth-positive
Trialjectory Boasts Over 54 Percent Growth in New Cancer Patient Users from Diverse Ethnic and Racial Backgrounds in Q1 2022
Customers
Jun 6, 2022 · www.prnewswire.com
growth-positive
Trialjectory Presents Poster Highlighting Platform's Effective Cancer Patient Clinical Trial Recruitment at 2022 ASCO Annual Meeting
CustomersPartners
Feb 7, 2022 · www.mobihealthnews.com
growth-positive
Trialjectory scores $20M to match cancer patients to clinical trials
Investment
Nov 12, 2021 · techcrunch.com
growth-positive
Trialjectory on track to match 50K cancer patients with clinical trials this year: 35% are from underrepresented groups
Customers
Sep 27, 2021 · pharmaphorum.com
growth-positive
YonaLink, TrialJectory get $1m grant for patient recruitment tool -
PartnersInvestment
growth-positive
Clinical Trial Matching Startup's Survey Spotlights NGS Access Barriers, Patient Awareness
Customers
Aug 17, 2021 · www.forbes.com
growth-positive
Startup Helps Cancer Patients Find Clinical Trials, Offering New Hope And More Options
Customers
Mar 26, 2021 · www.cancernetwork.com
growth-positive
Tzvia Bader Discusses the TrialJectory Platform Connecting Patients With Cancer to Clinical Trials
CustomersPartners
Mar 9, 2021 · www.prnewswire.com
growth-positive
TrialJectory Achieves 500 Percent Year-Over-Year Growth as Cancer Patients and Pharmaceutical Industry Increasingly Leverage Proprietary AI Platform in COVID-19 Pandemic
CustomersPartnersInvestment
Nov 20, 2020 · www.wfmz.com
growth-positive
TIME Selects TrialJectory's AI-Powered, Clinical Trial-Matching Platform for '100 Best Inventions of 2020' List
CustomersPartners
Jan 28, 2020 · www.prnewswire.com
growth-positive
TrialJectory and Precipio Partner to Provide Cancer Patients with First-of-its-Kind Diagnostic and Clinical Trial-Matching Service
Partners
Dec 17, 2019 · techcrunch.com
growth-positive
Trialjectory uses self-reported clinical data to match cancer patients with clinical trials
InvestmentExpand
Nov 4, 2018 · www.calcalistech.com
growth-positive
This Startup Helps Patients Find their Best Shot at Surviving Cancer
CustomersInvestment
Details
Product Stage
Released
Employees
11-50
Exact Count
21
District
Center District
Founded
2017
Registrar
516091030
Crunchbase
trialjectory
Locations
King George Street 48, Tel Aviv-Yafo, Israel
700 Canal St, Stamford, CT, USA
Links
Website
LinkedIn
Facebook
Admin
Last Update
Dec 23, 2024
Verified by
Natalia Golczar
Claimed
Yes
Missing
markets
Team (6)
Tzvia Bader
Co-founder & CEO
Founder
Guy Gildor
Co-founder & CTO
Founder
Avital Gaziel
Co-founder & Head of Medical Affairs
Founder
Noam Barnea
Co-founder & VP Product
Founder
Noam Barnea
VP R&D
Rita Tochner
Head of Operations
Internal
Created by
Yotam Maman (yotamm1988@gmail.com)
Created
2018-11-05T00:00:00.000Z
Last editor
Yanina Wainscheinker (yanina.wainscheinker@sncentral.org)